Objective Our goal was to develop a tele-colposcopy platform for primary-care clinics to improve screening sensitivity and access. Specifically, we developed a low-cost, portable Pocket colposcope and evaluated its performance in a tertiary healthcare centre in Peru.
Introduction
Cervical cancer prevention is based on well-established interventions including human papillomavirus (HPV) vaccination and screening followed by treatment of preinvasive disease. [1] [2] [3] [4] In the USA, cervical cancer incidence has decreased by 70% over the last 60 years due to screening with the Papanicolaou (Pap) smear 5 and, more recently, co-testing for HPV; 1,2 however, women living in low-and middle-income countries (LMICs) † These authors contributed equally. experience a disproportionately high burden of cervical cancer. 6, 7 In Peru, women are screened using visual inspection with acetic acid (VIA); those who screen positive are referred to colposcopy-guided biopsy, which, if positive, requires another visit for treatment. [8] [9] [10] Colposcopy-guided biopsy is the reference standard for diagnosing suspected precancerous lesions of the cervix and involves the use of a low-magnification microscope. However, colposcopes are expensive, and so, women are referred to one of a handful of facilities that provide this service. Consequently, colposcopy is often inaccessible to the many women in LMICs who are at greatest risk for developing cervical cancer. [11] [12] [13] [14] [15] [16] [17] [18] [19] Being able to bring colposcopy to the screening setting could eliminate one step in the referral process. Further, replacing VIA with colposcopy at the initial screening could improve sensitivity. 6, 10, 20 Our ultimate goal was to introduce a tele-colposcopy platform into the primary-care setting to reduce multiple visits and improve screening sensitivity. Specifically, we have invented a low-cost, battery-operated Pocket colposcope that weighs less than 250 g. 21 Whereas traditional colposcopes visualise the cervix from outside the speculum, our design is used inside the speculum. The proximity of the colposcope to the cervix enables high-quality imaging of the cervix using consumer-grade light sources and cameras. Additionally, the Pocket colposcope can be connected to a smartphone for easy visualisation of the image. Based on an exploratory study conducted at the Duke University Medical Center, physician interpretation of aceto-whitened cervix images acquired with the Pocket colposcope was comparable to those obtained using a standard-of-care colposcope. 22, 23 Before introducing the Pocket colposcope into a screening setting in Peru, it is important to demonstrate that it can achieve comparable performance to a conventional standard-of-care colposcope in a referral setting within the same healthcare environment for which it is intended. Therefore, the performance of the Pocket and standard-ofcare colposcopes was compared in patients undergoing colposcopy at la Liga Contra el C ancer, a nongovernmental organisation that provides wide-scale screening and referral services for cervical cancer.
Methods
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The Pocket colposcope
The Pocket colposcope has gone through several iterations of speculum-based 21, 23 and speculum-free 24 designs. This study was conducted using the latest generations of the speculum-based Pocket colposcope, which feature a waterproof design that enables the user to submerge the probe in chemical agents for high-level disinfection between patient uses ( Figure 1A,B) .
Patient population
Images were collected with the Pocket and a standardof-care colposcope (Goldway SLC-2000B) at la Liga Contra el C ancer under Duke University Medical IRB approved protocol (Pro00052865). Two hundred Peruvian women with abnormal cytology and/or HPV positivity were enrolled in this study. Informed written consent was obtained from each patient. Patients were not involved in the development of the Pocket colposcope or study.
Imaging procedures
The speculum was placed in the vaginal canal, acetic acid was applied to the cervix, and then images were captured with the standard-of-care and Pocket colposcopes. Acetic acid was not re-applied immediately before imaging with the Pocket colposcope for the first 168 patients, but was re-applied for the last 32 patients to improve visualisation of aceto-whitening. After acetic acid application and imaging, Lugol's iodine was applied to the cervix and images were captured with both colposcopes. All clinical decisions were made with the standard-of-care colposcope, including guiding biopsy. To achieve high-level disinfection between patient uses, the Pocket colposcope was submerged in 0.0675% bleach for 10 minutes at 25°C, as per established guidelines. 25 
Image quality review
Cases were excluded from subsequent analysis if (1) images and/or pathology were missing (because statistics could not be calculated for incomplete cases), or (2) images were unreadable due to incorrectly focusing the device during image acquisition. To evaluate image quality, two reviewers separately viewed and scored each image as having low, medium or high image quality, which were defined as follows: 'high' image quality is in focus and all four quadrants of the cervix are visible, 'medium' image quality is slightly out of focus and most of the four quadrants of the cervix are visible, and 'low' image quality is not in focus and most of the four quadrants of the cervix are not visible. Discrepancies between the two reviewers were resolved by consensus review. Images with high or medium image quality were included in subsequent analysis.
Image interpretation
To remove bias, image pairs that passed image-quality review were cropped to remove the view of the speculum and vaginal side walls, thereby blinding the physician to which colposcope was used to acquire the image. Image pairs were split, randomised, labelled with a random identifier, and placed into different documents that were sent electronically to four physicians. Evaluation of each image by the physicians was performed remotely using an REDCap electronic survey. The survey includes the randomised identifier code, technical questions about the image quality and clinical questions evaluating the diagnosis of the cervical image. The physician responses to each question were automatically saved in our REDCap database. The data were exported to Microsoft EXCEL (Microsoft Office Professional Plus 2013, Redmond, WA, USA) for further analysis.
The physicians provided a diagnosis of normal cervix, cervical intraepithelial neoplasia grade 1 (CIN1), CIN2, CIN3 or cancer for each cervix image -CIN1 is considered a low-grade squamous intraepithelial lesion (LSIL), while CIN2 and CIN3 are considered high-grade SIL (HSIL). The physician diagnoses of the cervical images were compared with the pathology-confirmed diagnosis given as: normal, cervicitis, condyloma, no biopsy, CIN1, CIN2, CIN3 or invasive cancer. Pathological diagnosis was grouped as negative (normal, cervicitis, condyloma) versus precancer or cancer (CIN1-CIN3, cancer). Patients who were colposcopically normal did not undergo a biopsy procedure (i.e. no biopsy) according to the standard-of-care guidelines and were considered negative given that colposcopy has high sensitivity, but relatively low specificity.
Comparison with previous studies
Lugol's iodine was used as a secondary contrast agent in this study. To assess if the addition of Lugol's iodine improves the percent agreement between colposcopy and pathology, we analysed data from two previous studies in which similar numbers of acetic acid images only were captured with the same versions of the Pocket colposcope (Generation 3 and 4) and reviewed by the same physician.
22,23
Statistical analysis
All statistical analyses were performed in STATA version 13.0 (College Station, TX, USA). First, the percent agreement and j statistic between the Pocket and standard-of-care colposcopes were computed for multiple raters. Specifically, Fleiss' j statistics, which account for more than two possible ratings per image, were computed for both the Pocket and standard-of-care colposcopes to assess inter-observer variation across four physicians. Additionally, j statistics were computed for each physician to provide a measure of intra-observer agreement between the two colposcopes. Accuracy, sensitivity, specificity, positive predictive value and negative predictive value were calculated by comparing physician diagnoses of the cervical images with pathologyconfirmed diagnoses. The percentage of incorrect diagnosis was calculated by tabulating cases where the physician interpretation from colposcopy did not match the pathology. P values associated with percent agreement and j statistics are included in subsequent tables. A significance level of P < 0.05 was considered to reject the null hypothesis for all analyses.
Results
Image-quality review
A total of 129 image pairs met image-quality criteria and were retained for further analysis. A flow chart illustrating the process for image exclusion is shown in the supporting information Figure S1A , and representative examples of low-, medium-and high-quality images are also shown ( Figure S1B ). The reasons for exclusion of patient images are summarised in Figure S1C . Briefly, approximately 36% of cases (71/200) were excluded either because images or pathology were missing (17.5%; 35/200) or images were unreadable due to low image quality (18%; 36/200). Approximately half of the unreadable images were excluded because the first Pocket colposcope that was used in this study had technical malfunctions and was replaced once the problem was noted. The percentage of unreadable Pocket colposcope images decreased after the first 50 patients ( Figure S1D ) as providers became more familiar with operating and focusing the device. All other image exclusions were comparable between the Pocket and standard-of-care colposcopes.
Patient characteristics
Relevant patient information for the 129 patients included in our analysis is shown in the supporting information Table S1 . The mean age of women enrolled in our study was 37 years and ranged from 20 to 67 years. Previous Pap smear results were recorded for 27% of women in our study, two-thirds of whom had abnormal results. The remaining 73% of women had unknown Pap smear results that were not recorded in the la Liga Contra el C ancer database. Of the 129 women included in our analysis, 48 were diagnosed as colposcopically normal at the time of the procedure and therefore had no biopsy as per established screening guidelines. Biopsy-confirmed pathology from the remaining 81 women indicated that 20 women were negative for precancer or cancer, 39 had LSIL, 15 had HSIL and 7 had invasive cancer.
Comparison between Pocket and standard-of-care colposcopes
Representative image pairs captured with the Pocket colposcope and standard-of-care colposcope are shown in Figure 1C -R. Lesions in LSIL, HSIL and invasive cancer image pairs are readily seen in images acquired with both colposcopes. Aceto-whitened lesions were confirmed and somewhat enhanced with the addition of Lugol's iodine, which stains lesions a mustard yellow colour.
The percent agreements across the four physicians for the Pocket compared with the standard-of-care colposcope are shown in Table 1 . Physician interpretation of the colposcopy images acquired by the two different colposcopes was concordant for 83.1% of the images. The percent agreement increased from negative (82.2%) to LSIL (82.6%) to HSIL+ (86.4%) image pairs.
The j statistics were calculated to assess inter-and intraobserver agreement and are shown in Table 2 . The Fleiss' j statistics for the Pocket and standard-of-care colposcopes were 0.29 and 0.46, respectively, indicating that raters achieve fair to moderate inter-observer agreement. For CIN+ images, the Fleiss' j statistics for the Pocket and standard-of-care colposcopes were 0.26 and 0.30, respectively, indicating that raters achieve fair inter-observer agreement regardless of the colposcope used to capture the image for precancerous and cancerous lesions. Additionally, individual physicians achieved an average j coefficient of 0.61, indicating that raters achieve substantial intraobserver agreement between colposcopes.
Comparison between each colposcope and pathology
The average classification accuracy, sensitivity, specificity, PPV and NPV across physicians compared with pathology is shown in Figure 2A . For negative versus CIN+ patients, the average values across physicians were within 8.6% of each other for the two devices. The average accuracy, sensitivity and specificity were similar for the Pocket (accuracy = 63.9%, sensitivity = 71.2%, specificity = 57.5%) and standard-of-care (accuracy = 67.6%, sensitivity = 79.8%, specificity = 56.6%) colposcopes. For negative versus HSIL+ patients, the average values across physicians were within 1.6% of each other for the two devices. When compared with negative versus CIN+ patients, the overall accuracy and specificity remained approximately the same for negative versus HSIL+ patients; but, the sensitivity for negative versus HSIL+ patients increased compared with negative versus CIN+ patients for both colposcopes. Figure 2B shows the percentage of incorrect diagnosis for both colposcopes by pathological category. The highest overall percentage of incorrect diagnosis was for negative followed by LSIL image pairs. On average, physicians misdiagnosed three HSIL and two cancer images with the Pocket colposcope and two HSIL and two cancer images with the standard-of-care colposcope. A majority of misdiagnoses for cancer images acquired with both colposcopes were from a single patient, who had a cervix with atrophic changes and consequently was difficult to evaluate because of poor staining with both contrast agents. Overall the standard-of-care and Pocket colposcope achieved similar percentages of incorrect diagnoses -specifically, they were within 6% of each other for all individual pathological categories for all physicians.
Missed cases
Summary of results and comparison to previous studies
The supporting information Table S2 summarises the percent agreement, accuracy, sensitivity and specificity achieved in two previous studies in which acetic acid images only were reviewed compared with the current study in which both acetic acid and Lugol's iodine images were reviewed by the same physician. The overall percent agreement between the Pocket and standard-of-care colposcopes increased from 75.2 to 81.5% when Lugol's iodine was added. Furthermore, the percent agreement increased for all pathological categories, including negative (from 70.5 to 79.4%), CIN+ (from 79.0 to 83.9%), LSIL (from 75.0 to 82.1%) and HSIL+ (from 81.1 to 86.4%) when Lugol's iodine was added. For negative versus CIN+ patients, the accuracy increased from 63.4 to 69.0% for the Pocket colposcope and from 64.4 to 73.6% for the standard-of-care colposcope when Lugol's iodine was added. Similar increases were observed in sensitivity and specificity for negative versus CIN+ patients -sensitivity increased from 75.4 to 82.0% and specificity increased from 47.7 to 57.4% for the Pocket colposcope. Sensitivity increased from 82.5 to 88.5% and specificity increased from 40.9 to 60.3% for the standard-of-care colposcope when Lugol's iodine was used as a secondary contrast agent. For negative versus HSIL+ patients, the overall accuracy and specificity remained approximately the same compared with negative versus CIN+ patients; however, the sensitivity increased from 78.4 to 86.4% for the Pocket colposcope and from Table 1 . Percent agreement between the Pocket colposcope and standard-of-care colposcope stratified by pathology (all, negative, CIN+, LSIL and HSIL+) All, % (n = 129) Negative, % (n = 68) CIN+, % (n = 61) LSIL, % (n = 39) HSIL+, % (n = 22) 81.1 to 90.9% for the standard-of-care colposcope when Lugol's iodine was added.
Discussion
Main findings
The Pocket and standard-of-care colposcopes performed similarly when used to identify precancerous and cancerous lesions using acetic acid and Lugol's iodine as contrast agents. Specifically, physician interpretation of images from the two colposcopes agreed 83.1% of the time. Analysis of inter-and intra-observer agreement with j statistics indicated that physicians achieved fair and moderate interobserver agreement for the Pocket (0.29) and standard-ofcare (0.46) colposcopes, respectively, and achieved substantial intra-observer agreement between the two colposcopes (0.61). The average accuracies were 63.9 and 67.6% for the Pocket and standard-of-care colposcopes, respectively. The average sensitivity and specificity of the Pocket colposcope were 71.2 and 57.5%, while the average sensitivity and specificity of the standard-of-care colposcope were 79.8 and 56.6%. Adding Lugol's iodine as a secondary contrast agent improved the percentage agreement between colposcopes for all pathological categories by up to 8.9% and the accuracy of physician interpretation compared with pathology by up to 9.2%.
Strengths and limitations
One of the strengths of this study is the randomisation and blinding of the paired cervical images before being evaluated by the physicians. Specifically, physicians did not know which device was used to capture each image and could evaluate images without bias for or against one of the colposcopes. Additionally, histopathological confirmation was obtained for all patients who received a biopsy in this study, which provided an independent clinical standard against which the physician's interpretation from both colposcopes could be compared. Further, this study was completed in 129 patients in an international setting by health providers that were not directly involved in developing the device, which provides a better assessment of how the Pocket colposcope might perform in LMICs. Additionally, this study incorporated imaging of cervices stained with Lugol's iodine, which had not previously been imaged or validated with the Pocket colposcope. There were also several limitations or implementation challenges associated with this study, which are summarised in the Supplementary material (Table S3) . First, this is a preliminary study of a new device with a relatively small sample in a referral setting in Peru. Future studies will assess the performance of the Pocket colposcope with a larger patient population in a primary-care setting in an LMIC. Second, referral facilities only provided cytology to la Liga Contra el C ancer for 28% of patients; hence, cytology was unknown for a majority of cases in our study. Third, acetic acid was not re-applied immediately before imaging with the Pocket colposcope until the last 32 patients. 22, 26 Revising the study protocol in future studies to re-apply acetic acid between imaging with the two colposcopes could improve visualisation of aceto-whitening. Fourth, confirmatory pathology was not acquired for all patients in our study. Specifically, patients who were colposcopically normal according to standard-of-care colposcopy did not receive a biopsy because it would be considered a deviation not only from the standardof-care procedures at la Liga Contra el C ancer but also from World Health Organization's cervical cancer screening guidelines. Lastly, no relevant medical history was provided with the images, but physicians were aware that this study was conducted in a referral population. By providing relevant medical history, physicians may be able to more accurately stratify women by risk for follow-up.
Interpretation
We observed inter-observer and intra-observer variability among physician's image evaluation and diagnosis. The Fleiss' j statistic, which is a measure of inter-observer agreement, for the Pocket colposcope was 0.29 overall, indicating that raters achieve fair inter-observer agreement (between 0.21 and 0.40). 27 In comparison, the Fleiss' j statistic for the standard-of-care colposcope was 0.46 overall, indicating that raters achieve moderate inter-observer agreement (between 0.41 and 0.60). 27 The overall inter-observer agreement for the Pocket colposcope was lower than that for the standardof-care colposcope used in this study probably because aceto-whitening was fading when the Pocket images were acquired. For CIN+ images, the Fleiss' j statistics for the Pocket and standard-of-care colposcopes were 0.26 and 0.30, respectively, indicating that raters achieve fair interobserver agreement (between 0.21 and 0.40) regardless of the colposcope used to capture the image. Hence, j statistics indicated that the Pocket colposcope performed similar to a standard-of-care colposcope when used to identify precancerous and cancerous lesions; however, neither colposcope achieves substantial or perfect inter-observer agreement. A previous study of 540 cervical images, where acetic acid was used to stain features, found that the inter-observer agreement was mostly fair to moderate between providers with j statistics ranging from 0.33 to 0.54, 28 which is similar to the range of Fleiss' j statistics observed in this study. While inter-observer agreement in this study was fair to moderate, intra-observer agreement was substantial (between 0.61 and 0.80). Specifically, the average j statistic for the two colposcopes was 0.61. A previous study found that intra-observer agreement was substantial with j statistics ranging from 0.60 to 0.86 for the evaluation of 100 cervical images where acetic acid was used to stain features. 29 Our observation that intra-observer agreement is higher than inter-observer agreement is consistent with previous studies. Our study, along with other studies, reflects a need for improvement in colposcopist training to increase inter-observer agreement and mitigate the risk of misdiagnosis.
We found that the addition of Lugol's iodine as a secondary contrast agent improved the agreement between the two colposcopes for all pathological categories by 8.9% and the accuracy of physician interpretation compared with pathology by 5.6 and 9.2% for the Pocket and standard-ofcare colposcopes, respectively. Previous studies comparing the performance of VIA with visual inspection with Lugol's iodine (VILI) found similar diagnostic accuracy and rates of CIN2+ detection; 30, 31 however, no studies have been conducted that assess the additive diagnostic accuracy of VIA + VILI.
Incorporating vascular imaging into colposcopy examinations has the potential to further improve accuracy as neovascularisation is reflective of high-grade lesions. 32, 33 In traditional colposcopy, a green filter is placed in front of the camera to enhance the visualisation of vascularisation, which as a result of haemoglobin's strong absorption of green light makes vasculature appear black. 34 In the USA, standard colposcopy includes imaging the cervix with both white and green light. At la Liga Contra el C ancer, green light colposcopy is available but rarely used by the physicians to make a diagnosis and therefore was not implemented in this study. A study that systematically compares the benefits of using Lugol's iodine and acetic acid imaging with both white and green light may provide the justification for leveraging all three sources of contrast.
Conclusion
Our goal is to incorporate the Pocket colposcope into a tele-colposcopy platform that could be used at multiple points in the care pathway in LMICs, including primarycare clinics where it could replace VIA as a screening tool, and referral centres where it could be used to guide biopsy (if available) and identify lesion location before treatment. The Pocket colposcope performance was similar to a standard-of-care colposcope when used to identify precancerous and cancerous lesions using acetic acid and Lugol's iodine during colposcopy examinations in Peru. This type of point-of-care diagnostic combined with tele-colposcopy for expert physician review of images could be used as a means of reducing the morbidity and mortality of cervical cancer in Peru and elsewhere.
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